Mesenchymal Stem Cells: A Trump Card for the Treatment of Diabetes?
The advent of the new revolutionary approach based on regenerative medicine is progressively reshaping the therapeutic scenario of many different diseases, such as cardiovascular diseases and immune diseases, with encouraging results. During the last 10 years, many studies have also proposed the use...
Main Authors: | Elisabetta Donzelli, Arianna Scuteri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/5/112 |
Similar Items
-
Current progress in stem cell therapy for type 1 diabetes mellitus
by: Shuai Chen, et al.
Published: (2020-07-01) -
Mesenchymal Stem Cells as New Therapeutic Approach for Diabetes and Pancreatic Disorders
by: Arianna Scuteri, et al.
Published: (2018-09-01) -
Electrofusion of Mesenchymal Stem Cells and Islet Cells for Diabetes Therapy: A Rat Model
by: Yanai, Goichi
Published: (2015) -
Subcutaneous transplantation of engineered islet/adipose-derived mesenchymal stem cell sheets in diabetic pigs with total pancreatectomy
by: Mampei Yamashita, et al.
Published: (2021-03-01) -
Human Hemangioblast-Derived Mesenchymal Stem Cells Promote Islet Engraftment in a Minimal Islet Mass Transplantation Model in Mice
by: Suzanne Bertera, et al.
Published: (2021-04-01)